MML Capital Partners has invested into The Luneau Technology Group (“Luneau”). Luneau is a world leader in the supply of diagnostic equipment, analysis and testing in ophthalmology, refractive optometry equipment and cutting equipment and mounting opticians. Luneau operates in 9 countries, and sells into over 100.
We use cookies on this website to collect data for analytics purposes. This allows us to understand how our website is being used so we can create the best experience for you. For further details on our use of cookies, please see our Privacy Policy and Cookies Policy. If you are happy for us to use these cookies, please click “Accept”. If not, please click “Reject”.
You can revoke your consent any time using the revoke consent button.